Arthrogen B.V., a subsidiary of MeiraGTx B.V., is an Amsterdam based biopharmaceutical company developing local gene therapy for different indications, using viral mediated gene transfer. Arthrogen specializes in the development of viral gene therapy vectors, in particular adeno-associated virus (AAV-) based therapeutics. Several product candidates are in the discovery and development phase. In our programs, we collaborate with world leading scientists. The company is based on the premises of the AMC/University of Amsterdam in Amsterdam.
Arthrogen B.V., a subsidiary of MeiraGTx B.V., is an Amsterdam based biopharmaceutical company developing local gene therapy for different indications, using viral mediated gene transfer. Arthrogen specializes in the development of viral gene therapy vectors, in particular adeno-associated virus (AAV-) based therapeutics. Several product candidates are in the discovery and development phase. In our programs, we collaborate with world leading scientists. The company is based on the premises of the AMC/University of Amsterdam in Amsterdam.
Company Information
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Meibergdreef 45 Nord-Holland Amsterdam
- City
- Heemskerk
- Region
- Noord-Holland
- Postal Code
- 1105BA
- Country
- Netherlands
